FindTrial
Sign In

Study of treatment and disease complications of Type I Diabetes mellitus patients in India

A pRospective, obsErvational, multicenter Study to evaluate cOmplications and treatmeNt modAlities in Type-I diabEtes mellitus patients across India. - RESONATE- I

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017088
Enrollment
500
Registered
2019-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E108- Type 1 diabetes mellitus with unspecified complications

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Aprica Healthcare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participant/Legally Accepted Representatives/Parents/Guardians who are willing to provide written Informed Consent Form or participantâ??s LAR or guardian willing to provide written informed consent form 2. Male or female of up to 35 years of age 3.Diagnosed with type 1 diabetes mellitus based on clinical judgement and supported by laboratory analysis as per local guidelines 4.Patients receiving injectable insulin or its analogue

Exclusion criteria

Exclusion criteria: 1. Past history of diabetic ketoacidosis requiring hospitalization within the last 90 days prior to the baseline visit 2. Patients with any other type of Diabetes except Type I Diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Efficacy of treatment by measuring glycemic control with treatment - PPBS, FBG and HbA1CTimepoint: 3 months—

Secondary

MeasureTime frame
Patient demography, Treatment duration and associated complicationsTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Amit Gajjar

Aprica Healthcare Pvt Ltd,

dramit@aprican.com7573953504

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026